Literature DB >> 16365211

Comparison of valve structure, valve weight, and severity of the valve obstruction in 1849 patients having isolated aortic valve replacement for aortic valve stenosis (with or without associated aortic regurgitation) studied at 3 different medical centers in 2 different time periods.

William Clifford Roberts1, Jong Mi Ko, Cody Hamilton.   

Abstract

BACKGROUND: Aortic valve replacement (AVR) for patients with aortic stenosis (AS) has now been available for 45 years. During this period, indications for the procedure have changed. METHODS AND
RESULTS: Operatively excised stenotic aortic valves (with or without associated aortic regurgitation and without associated mitral valve disease) from 3 different medical centers (National Institutes of Health, Georgetown University Medical Center, and Baylor University Medical Center) were examined during 2 different time periods by the same physician to compare aortic valve structure, valve weight, age at operation, preoperative transvalvular peak pressure gradient, calculated aortic valve area, and whether simultaneous coronary artery bypass grafting (CABG) was performed. Compared with the first 3 decades (1961-1990) of AVR, patients having this operation during the fourth and fifth decades (1991-2004) had a lower frequency of congenitally malformed aortic valves, a higher frequency of tricuspid aortic valves, an older age, valves of lighter weight and lower transvalvular peak pressure gradients, and more often simultaneous CABG.
CONCLUSIONS: Although patients having isolated AVR for AS in the present and last decade were older than in the first 3 decades of valve replacement surgery, congenitally malformed aortic valves continue to be more common than tricuspid aortic valves, but the degree of AS and therefore, valve weight was significantly lower than in the earlier decades.

Entities:  

Mesh:

Year:  2005        PMID: 16365211     DOI: 10.1161/CIRCULATIONAHA.105.543280

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  William Clifford Roberts, MD: an interview by W. Bruce Fye, MD.

Authors:  William C Roberts; W Bruce Fye
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-07

2.  Some observations on mitral and aortic valve disease.

Authors:  William Clifford Roberts; Jong Mi Ko
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-07

3.  Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease.

Authors:  Loren E Dupuis; Daniel R McCulloch; Jessica D McGarity; Alexandria Bahan; Andy Wessels; Deidra Weber; A Megan Diminich; Courtney M Nelson; Suneel S Apte; Christine B Kern
Journal:  Dev Biol       Date:  2011-07-01       Impact factor: 3.582

4.  Circulating soluble receptor for advanced glycation end product identifies patients with bicuspid aortic valve and associated aortopathies.

Authors:  Emanuela Branchetti; Joseph E Bavaria; Juan B Grau; Richard E Shaw; Paolo Poggio; Eric K Lai; Nimesh D Desai; Joseph H Gorman; Robert C Gorman; Giovanni Ferrari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-08-14       Impact factor: 8.311

Review 5.  Review of molecular and mechanical interactions in the aortic valve and aorta: implications for the shared pathogenesis of aortic valve disease and aortopathy.

Authors:  Varun K Krishnamurthy; Richard C Godby; G R Liu; J Michael Smith; Loren F Hiratzka; Daria A Narmoneva; Robert B Hinton
Journal:  J Cardiovasc Transl Res       Date:  2014-11-20       Impact factor: 4.132

6.  Endothelial nitric oxide synthase alterations are independent of turbulence in the aorta of patients with a unicuspid aortic valve.

Authors:  Brittany Balint; Catherine Kollmann; Simon Gauer; Jan M Federspiel; Hans-Joachim Schäfers
Journal:  JTCVS Open       Date:  2021-08-21

7.  Discovery of an Experimental Model of Unicuspid Aortic Valve.

Authors:  Robert M Weiss; Yi Chu; Robert M Brooks; Donald D Lund; Justine Cheng; Kathy A Zimmerman; Melissa K Kafa; Phanicharan Sistla; Hardik Doshi; Jian Q Shao; Ramzi N El Accaoui; Catherine M Otto; Donald D Heistad
Journal:  J Am Heart Assoc       Date:  2018-06-30       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.